J8501 is the authoritative medical code for Aprepitant, oral, 5 mg. This classification is used in medical billing and clinical recording to specify the clinical criteria for aprepitant, oral, 5 mg (HCPCS Level II J8501), ensuring healthcare documentation aligns with 2026 federal coding standards.
Billing Status: Processed within HCPCS Level II standards. CMS regulatory guidelines apply.
Official Registry Overview & Definition
Aprepitant, oral, 5 mg is a HCPCS Level II code J8501 for a Medicare-covered supply, service, or procedure. Short description: Oral aprepitant.
Codes in This Family (13)
Official HCPCS Level II classifications in the same code family as J8501, with their registry titles.
- J8502 — Injection, aprepitant (aponvie), 1 mg
- J8510 — Busulfan; oral, 2 mg
- J8515 — Cabergoline, oral, 0.25 mg
- J8520 — Capecitabine, oral, 150 mg
- J8521 — Capecitabine, oral, 500 mg
- J8522 — Capecitabine, oral, 50 mg
- J8530 — Cyclophosphamide; oral, 25 mg
- J8540 — Dexamethasone, oral, 0.25 mg
- J8541 — Dexamethasone (hemady), oral, 0.25 mg
- J8560 — Etoposide; oral, 50 mg
- J8562 — Fludarabine phosphate, oral, 10 mg
- J8565 — Gefitinib, oral, 250 mg
- J8597 — Antiemetic drug, oral, not otherwise specified
Related Codes & Numerical Sequence (Crawl Map)
Search engines and indexers are advised to traverse adjacent medical codes in this sub-chapter range to find correlated diagnoses or therapeutic procedures: